Vivalytic Powered by Randox Biochip Technology: Upper and Lower Respiratory Tract Testing
Vivalytic Powered by Randox Biochip Technology: Upper and Lower Respiratory Tract Testing
15 November 2019
Vivalytic Powered by Randox Biochip Technology: Upper and Lower Respiratory Tract Testing
Vivalytic will revolutionise the way laboratories and healthcare professionals access molecular diagnostics. A result of a collaboration between Bosch – providing innovative strength – and Randox Laboratories – dedicated to improving global healthcare – Vivalytic is the new innovative testing platform. It’s the perfect fit for any laboratory, with numerous benefits to enhance testing capabilities.
The Vivalytic is a fully-automated, cartridge-based platform capable of both Hi-Plex and Lo-Plex testing. Vivalytic cartridges are compact, utilising micro-fluidics to enable simple and accurate diagnostic testing. Hi-Plex tests utilise Randox patented Biochip Technology, enabling end-point qualitative PCR and providing multiple test results from each sample. Lo-Plex tests are based on a variety of detection methods including real-time qualitative PCR and melting curve analysis. Nucleic acid extraction, PCR amplification followed by a suite of detection methods are combined in a truly revolutionary platform. Manual preparation, cold chain reagents and the use of multiple devices are no longer required.
Vivalytic is the perfect fit for a healthcare professional in a point of care setting to a laboratory, which can implement the Vivalytic Up – modular and expandable testing system for higher throughput.
Benefits include:
- Fully Automated Platform
- Protected System
- Direct and Clear Results
- Hygienic and Space Saving
Vivalytic Test Menu
Vivalytic offers the most comprehensive multiplex screening test for infectious diseases including respiratory, genitourinary and hospital acquired infections; simultaneously detecting both viral and bacterial infections (please see figure 1.).
| Respiratory Tract Infection Array | Sexually Transmitted Infection Array | Hospital Acquired Infections | |
| Bacterial | Viral | ||
| Bordetella Pertussis | Influenza A | Chlamydia trachomatis (CT) | Methicillin-resistant
Staphylococcus aureus (MRSA) |
| Chlamydophila pneumoniae | Influenza B | Ureaplasma urealyticum (UU) | Methicillin-sensitive
Staphylococcus aureus (MSSA) |
| Haemophilus influenzae | Human adenovirus A/B/C/D/E | Neisseria gonorrhoea (NG) | Methicillin-resistant
coagulase-negative Staphylococci (MRCoNS) |
| Legionella pneumophila | Human bocavirus 1/2/3 | Mycoplasma genitalium (MG) | |
| Moraxella catarrhalis | Human coronavirus 229E/NL63 | Trichomonas vaginalis (TV) | |
| Mycoplasma pneumoniae | Human coronavirus OC43/HKU1 | Haemophilus ducreyi (HD) | |
| Streptococcus pneumoniae | Human enterovirus A/B/C | Mycoplasma hominis (MH) | |
| Bordetella parapertussis | Human Metapneumovirus | Treponema pallidum (TP) | |
| Human parainfluenza virus 1 | Herpes simplex Virus 1 (HSV-1) | ||
| Human parainfluenza virus 2 | Herpes simplex Virus 2 (HSV-2) | ||
| Human parainfluenza virus 3 | |||
| Human parainfluenza virus 4 | |||
| Human respiratory syncytial virus A & B | |||
| Human rhinovirus A/B/C | |||
Figure 1.
Lower and Upper Respiratory Tract Infections
The economic burden of respiratory illness in the UK costs a staggering £11 billion every year on lung disease alone1. Lower respiratory tract infections (LRIs) are a substantial public health problem and a leading cause of illness and death in people of all ages2. It is estimated that LRI causes nearly 4 million deaths annually3. Upper respiratory tract infections (URIs) account for an estimated 10 million outpatient appointments a year. Most of these appointments end with physicians needless writing of antibiotic prescriptions4.
Randox Biosciences offers a Respiratory Multiplex Array which rapidly detects and identifies the cause of 22 bacterial and viral pathogens helping to reduce the risk of antibiotic resistance. Given that only bacterial infections can be treated with antibiotics, rapid diagnostic tests are urgently needed to distinguish between bacterial and viral infections. This test will aid clinicians in their selection of the most appropriate antibiotic treatment for patients. GPs would have additional efficiency savings for the NHS, by eliminating the need for lengthy microbiology lab tests and unnecessarily writing prescriptions.
The test is performed utilising our Biochip Technology which enables the simultaneous detection of multiple results from one patient sample. Biochip Technology powers Vivalytic which is the all-one solution for molecular diagnostics.
The main benefits of the Respiratory Multiplex Array are:
- Turnaround time of 2 hours
- Validated for sputum, lavage and nasopharyngeal samples
- Panel includes viral and bacterial species to consolidate testing
Randox Biosciences are committed to the ongoing development of diagnostic tests, through our research into numerous disease areas, to improve health worldwide.
MEDICA World Forum for Medicine International Trade Fair
Randox Biosciences team will be attending Medica from the 18th – 21st of November 2019 at Messe Dusseldorf, Germany. Stop by and say hello to some of our team members at our stand, and to learn more about our latest game-changing partnership with Bosch – the innovative Vivalytic platform!
Medica is at the forefront of new approaches in laboratory medicine, addressing the complexity of an evolving healthcare landscape. This event attracts more than 5,100 exhibitors from 70 countries, engaging diverse professionals enabling them to discover new and innovative solutions to improving patient outcomes through effective lab testing, diagnosis and treatment.
To learn more about the Vivalytic offering, visit https://www.randoxbiosciences.com/clinical-laboratory/infectious-diseases/molecular-arrays/ or email us at info@randoxbiosciences.com
References:
- British Lung Foundation. (2019). Estimating the economic burden of respiratory illness in the UK. [online] Available at https://www.blf.org.uk/policy/economic-burden [Accessed 06 Nov. 2019].
- The Lancet Infectious Diseases. (2015). Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. [online] Available at https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30396-1/fulltext [Accessed 29 Oct. 2019].
- Forum of International Respiratory Societies. The Global Impact of Respiratory Disease – Second Edition. Sheffield, European Respiratory Society, 2017.
- Thomas, M. and Bomar, P. The National Centre for Biotechnology. Upper Respiratory Tract Infection. United States of America.
RESEARCH
BIOPHARMA
CLINICAL LAB
BIOREAGENTS
Practical steps for dealing with substance misuse in the workplace
11 November 2019
Practical steps for dealing with substance misuse in the workplace
What is substance misuse?
Substance misuse (or abuse) is defined as the sustained use of any mind-altering substance. This includes legal substances like solvents and alcohol as well as illegal drugs. Through this continued use the user’s physical and mental health are severely affected. The misuse of substances in the workplace can cause issues such as increased absenteeism, low productivity and create an unsafe working environment.
It is estimated that between 3% and 5% of all work absences are due to alcohol abuse and that 1 in 30 employees has had drugs in their system at one time in the workplace. All employers have a legal responsibility to ensure the health, safety and welfare of their employees and so statistics like this cannot be ignored.
What can employers do?
As an employer, it is important that measures are taken to protect all employees and the company from potential dangers. To do this, employers should:
Introduce a comprehensive drug and alcohol policy. This lets all stakeholders know exactly where the company stands on substance misuse and shows that you are being proactive in your approach.
Conduct drug and alcohol testing. Utilising random and/or with cause testing can help quickly identify any substance misuse issues. Consider including a contractual obligation for employees to co-operate with this.
Train staff to identify the signs of substance misuse. Make everyone aware of the issue and give them the ability to look for the key signs. This can only help increase safety.
Keep up-to-date with the latest legislation. The laws on substance misuse can change quite quickly, especially as new substances like legal highs are identified and re-classified. Ensure you are aware of the latest changes.
Support employees. Addiction or frequent misuse of substances should be treated the same way as other health issues. Offer support to your employees and help them make a quick return to work.
The above steps can help better manage the issue of substance misuse in the workplace. Effectively communicating the company’s stance on this issue to employees brings clarity and lets everyone know where they stand.
Randox Testing Services
At Randox Testing Services we offer comprehensive drug and alcohol testing solutions for workplaces. We incorporate cutting-edge screening methods to provide an outstanding testing service and are well-positioned to provide consultancy and support to help you put an effective workplace drug and alcohol testing policy in place.
For more information contact us at testingservices@randox.com.
Want to know more?
Contact us or visit our website to read more.
Randox IT wins IT Project Team of the Year at Belfast Telegraph IT Awards
Congratulations to the Randox IT department who have been named as the ‘IT Project Team of the Year’ at the Belfast Telegraph IT Awards 2019!
The awards ceremony, which was an inaugural event from the Belfast-based media outlet, was a showcase of the finest that the Northern Ireland IT industry has to offer, with both IT agencies and in-house IT teams vying for the chance to be crowned among the best their respective fields.
Sarah Little, Publishing Director at INM(NI), said on the night that holding the event was a ‘no brainer’ due to the prolific growth of the IT sector in Northern Ireland. In 2018 1 in 9 jobs advertised were in IT.
Prior to the awards event, Randox IT had been shortlisted for both IT Project Team of the Year for their work on RIQAS Point of Care and IT Team of the Year for their work on the Randox Health client portal.
The in-house IT team at Randox comprises of web developers, engineers, customer support staff, web designers, security professionals, software development and software testers spanning ten nationalities, from Indian to Hungarian and Italian to South African.
In the last year Randox IT have worked on a variety of exciting and important projects, including the development of an innovative health portal that assesses the accuracy and reliability of point-of-care machines. These blood testing analysers are increasingly being placed in the likes of pharmacies, GP surgeries, and A&E departments to provide NHS Health Checks and manage long-term conditions.
It was for this work on RIQAS Point of Care that on Friday 8th November, at a glittering awards event in the MAC Belfast, Randox IT were officially named IT Project Team of the Year.
The cloud-based technology developed by Randox IT provides confidence in vital test results for conditions like diabetes and heart disease. Uptake of the scheme has increased considerably since it was launched this year, proving that the system is meeting a need for a quality assurance system for non-laboratory health service staff which was not being met before.
We are delighted that Randox IT have been recognised for this pioneering work in point-of-care software and hope you join us in congratulating them on such a tremendous achievement.
To find out more about Randox IT and the vacancies we have in the team, please email recruitment@randox.com
Want to know more?
Contact us or visit our Randox Careers
Find out more about Randox Careers
Careers News
Vacancies
Our People
Careers Website
Randox products go paperless in environmental friendliness initiative
In the latest on a list of initiatives aimed at improving its environmental friendliness, Randox Laboratories has announced the removal of IFUs from its products, in a bid to go paperless.
As of 1st June 2019, all Randox Reagent, ELISA and QC kits no longer contain a copy of the product’s IFUs (Instructions For Use), to aid in reducing our carbon footprint.
Did you know, in the US, office copy paper alone still accounts for over 20% of total paper usage?
Randox is committed to reducing our environmental impact across all areas of the business, and going paperless will go a long way in contributing to the efforts the company already makes to be more environmentally-friendly.
We also have a dedicated Environmental team whose role it is to prevent pollution, reduce waste, recycle consistently, and in general, to control and reduce the risks to air, land and water.
Each year the team plants a new area of trees around Lough Neagh in Northern Ireland, where our headquarters are located, to make sure the area continues to develop and flourish, and to maintain the wildlife diversity.
And it’s not just the Environmental team who endeavour to reduce our atmosphere emissions and energy use. Whether a scientist or marketer, manufacturing operative or salesperson, each member of Team Randox makes an effort to reduce our waste where we can – for example by turning off our computers, heating and lighting when not in use, and maintaining our equipment properly in order to maximise their efficiency.
Our engineering and manufacturing team, in particular, take environmental factors into consideration daily – whether the material they have chosen is environmentally friendly, if their processes are efficient and if waste material can be recycled.
Our training department also went paperless recently. Rather than completing training documentation on paper, the team is now utilising a paperless data management system to reduce our impact on the environment even more.
And instead of IFUs being included within Randox product kits, they will all now be available for download on randox.com.
To access your Randox kit inserts please follow the steps below;
1. Under the “Support & Documentation” tab on Randox.com, you will be presented with a number of options. Under the ‘Product Inserts’ tab, you will be able to access:
-Kit inserts for Reagents (including RX series)
-Kit inserts for ELISAs
2. You will be required to login, or to create an account by clicking “Request Access.”
– Upon logging on, you will be able to select a general insert, RX series insert, ELISA insert and so on.
– Alternatively, you can search for a specific cat code using the search field on the right. You can also opt for the results to display in ascending or descending order and then simply search for the kit.
Please see below a breakdown of how to access Randox IFUs on Randox.com.
Also listed under the “Support & Documentation” tab on Randox.com are the following useful tabs:
• QC / Calibrator Documents
– IFUs and value sheets for QC material and calibrators
– No log-in required
• MSDS
– Material safety data sheets for all products
– No log-in required
Randox places great importance on looking after the environment and reducing our carbon footprint.
We are constantly trying to find more ways to reduce environmental impact, contribute to the reduction of global CO2 emissions, and make sure that the area of outstanding natural beauty in County Antrim in which we work is preserved for many generations to come.
Should you have any questions about how to access Randox Instructions For Use online, please contact applications@randox.com
For further information on what we do at Randox to protect the local environment, please contact the Randox PR Team: phone 028 9442 2413 or email randoxpr@randox.com
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our Randox Products and Services
REAGENTS
RX SERIES
ACUSERA
BIOCHIP
We Are Randox | CĆ©line skydives into fundraising for AWARE NI
We’re passionate about celebrating the kindness and generosity of our Randox employees. Each have their own unique and interesting story to tell and many give up their spare time to support their local community and help those in need.
Their compassion and commitment is what makes Randox the successful company it is today, and this month Customer Relationship Executive, Céline Hasson, emulated this perfectly, with an adrenaline-filled display of bravery and dedication!
On Sunday 3rd November, Céline took to the skies for a charity skydive, in aid of our 2018/2019 charity partner, AWARE NI.
Below Céline explains why she wanted to take part in the charity skydive, and what it meant to her to be able to raise funds for the main depression charity for Northern Ireland.
Céline Hasson, Customer Relationship Executive, said;
“People with mental health conditions deserve as much support and compassion as those will physical health conditions. So with this in mind, back in May I signed myself up for a skydive, with a goal to fundraise £500+ for AWARE NI.
“Unfortunately the weather was against us on a number of the occasions we had previously planned to Skydive, but we got there in the end and were able to complete the challenge in November.
“I’m sure every person reading this has either suffered or knows someone who has/is suffering from depression, so please donate to a great cause like AWARE NI. Let’s support them to help support others.”
Did you know?
– 1 in 4 people will experience some kind of mental health problem each year
– Anxiety and depression are the most common mental disorders
– Overall prevalence of mental health conditions in Northern Ireland is up to 25% higher than in England
– 9 out of 10 people with mental health problems experience stigma and discrimination
What can you do?
Whilst Céline committed to a skydive with Moonjumpers Sky Diving, you have the easy part.
Simply make a donation and contribute to the very worthy AWARE NI, which has an established network of 24 support groups in rural and urban areas across the county, and also delivers mental health and well-being programmes into communities, schools, colleges, universities and workplaces.
To view Céline’s JustGiving page please visit; https://www.justgiving.com/fundraising/celine-hasson1
For further information about Randox’s charity work with AWARE NI in 2018/19, or our new charity partners in 2019/20, please contact the Randox PR team by emailing randoxpr@randox.com or phoning 028 9442 2413.
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our Randox Products and Services
REAGENTS
RX SERIES
ACUSERA
BIOCHIP
We Are Randox | Randox Men’s GAA team win Junior Shield at Inter-Firms competition
Randox Men’s GAA team win Junior Shield at FinTrU Ulster GAA Football Inter-Firms competition
After the success of the Randox Ladies GAA team in reaching their shield final at the FinTrU Ulster GAA Football Inter-Firms competition, Randox fielded two teams in the men’s competition which took place at Queen’s University Playing Fields Dub Pavilion on Saturday 26th October.
The men’s teams were pooled in separate groups with strong opposition facing both teams.
John James Fallon, Randox Electrical Engineer and Bainisteoir / Coach for Randox GAA commented;
“As soon as the day began the Randox men battled hard. With some fantastic individual performances and a relentless team effort we both recorded wins in our opening matches.
“Randox two lost out narrowly to solid Deloitte and CITI teams but bounced back in their last group game to win against Global Payments.
“Randox one continued strongly throughout the group stages impressively winning all but one of their group matches which saw them qualify for the shield final against Deloitte.
“The final was an even contest with both teams exchanging some fantastic scores in a very competitive game, but it was Randox who edged it and won the Junior Shield.
“What a great year for the Randox men and women. Many were playing GAA for the first time and both reaching the finals of their respective competitions. We fielded players ranging from experienced to novice and together what we achieved has been exceptional.
“On behalf of the organising committee I would like to say thank you to sponsor FinTrU and Ulster GAA for organising another fantastic day out, to Dr FitzGerald and the company for their continued support, but most importantly thank you to everyone who registered for this year’s competition.
“To everyone who played with such grit and determination, you have done yourselves and the company proud. A massive congratulations is in order for everyone, and in particular for Shay McStravick who captained the team on their win and lifted the Shield for Randox.”
Shay McStravick, Randox Men’s GAA Captain commented;
“I would like to congratulate all the men and women who took part in a hugely successful year for Randox GAA. Over the course of a couple of months we have built a great sense of camaraderie among the group and it was great to achieve some silverware to show for it.
“I would like to reiterate everything John James has already touched on and also take this opportunity to extend a huge thank you, on behalf of the team, to John James for all his hard work and commitment to help get Randox GAA on its feet. Here’s to 2020.”
We are all looking forward to next year already!
If you are interested in joining a Randox GAA team or helping out, please send your name and contact details to John James Fallon in our engineering team: johnjames.fallon@randox.com
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our Randox Products and Services
REAGENTS
RX SERIES
ACUSERA
BIOCHIP
Canine infection test redesigned to create less laboratory wastage
23 October 2019
New Randox Canine CRP Test
Canine infection test redesigned to create less laboratory wastage
A new smaller veterinary test kit for the diagnosis of viral and bacterial infections in dogs has been unveiled by global diagnostics company Randox Laboratories.
Suitable for the testing of a wide range of breeds, the test, which monitors levels of C-Reactive Protein (CRP) produced by the liver in response to inflammation, infection and tissue injury, has been redesigned in a smaller size to reduce consumable wastage.
Randox Canine CRP can diagnose conditions such as pancreatitis (inflammation of the pancreas), cystitis (a bladder infection) and inflammatory bowel disease, and can also be used to establish if a dog is pregnant.
Lynsey Adams, Randox Clinical Marketing Manager, commented;
“The redesign of our Canine CRP kit size, which has reduced the volume of the CRP reagent for the diagnosis of canine infection, means that laboratories will produce less waste, and ultimately, be more cost-effective.
“The wide measuring range of this test allows for slight variations of normal ranges across different canine species and ensures accurate results for all breeds.”
Concentration levels of CRP elevate in the blood of canines much earlier post-injury or infection than other biomarkers. This rapid response following trauma (usually within 4 to 6 hours), as well as the fact that CRP levels return to normal quickly at the end of an acute episode, make Canine CRP useful for both the detection of acute inflammation episodes and the monitoring of its treatment, such as steroids or antibiotics.
Lynsey continued;
“As in humans, CRP is used as a marker of inflammatory activity, but with the Randox Canine CRP test, which uses the same high-quality materials as our human assay, CRP can also be tested in dogs to establish a range of viral and bacterial infections.
“As CRP in healthy dogs is present in low concentrations (5 mg/dl), but can elevate to 600 mg/dl, testing for this biomarker can not only detect inflammation but also provide information on its severity.”
The new test from Randox enhances an already comprehensive veterinary test menu of high performance and superior animal health assays including Bile Acids, D-3 Hydroxybutyrate (Ranbut), Glutathione Peroxidase (Ransel) and Total Antioxidant Status, for agriculture and livestock, companion animals, university and research institutes, and the sports industry.
Randox veterinary solutions also include quality control, external quality assessment (EQA) and the RX series range of clinical chemistry analysers.
Lynsey concluded;
“We have over 30 years’ experience as a supplier to the veterinary market and are proud to be able to offer veterinarians and other professionals in the animal health industry, tests which are of the highest quality, accuracy and efficiency.
“Offering the complete veterinary diagnostics package of clinical chemistry analysers, reagents, and quality control, Randox is transforming the landscape of veterinary diagnostics, by providing a time and cost effective, flexible and versatile approach to animal health testing.”
Benefits of the new Randox Canine CRP Kit
- Immunoturbidimetric method.
- New kit size – R1 2 x 18.1ml, R2 2 x 5ml offering efficiencies in cost and reagent wastage.
- Wide measuring range of 0.8 – 220mg/dl for the comfortable detection of clinically important results. CRP in healthy dogs can be found at levels below 35 mg/L, therefore Randox Canine CRP comfortably detects abnormal levels.
- In addition, a wide measuring range allows for slight variations of normal ranges across different canine species and ensures accurate results for all.
- Liquid ready-to-use reagents for convenience and ease of use.
- Calibrator included in the kit offering a cost effective canine CRP testing solution.
- Dedicated canine CRP controls available offering a complete testing package.
- Instrument specific applications available for a wide range of clinical chemistry instruments.
For further information about Randox’s New Canine CRP kit please visit https://www.randox.com/canine-crp/ or contact marketing@randox.com
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our Randox Products and Services
REAGENTS
RX SERIES
ACUSERA
BIOCHIP
Drug Abuse Screening in the Emergency Department
21 October 2019
Drug Abuse Screening in the Emergency Department
On a global scale, emergency departments have been providing critical access to the health care system for many years, however, more recently visits to the emergency department has been an opportunity to identify patients with substance use disorders. Screening patients for illicit drugs and drug abuse has become increasingly more regular when a patient is admitted to the emergency department. Screening is vital to treat a patient with effective treatment. Nearly half of all emergency department visits in the US are categorized as relating to substance use disorders.
In a study completed at Ghent University Hospital in 2017 it was found that the most frequently reported drugs abused by emergency department patients are cannabis, cocaine, amphetamines, and opiates. It is important to screen patients in the emergency department if the patient is showing signs of confusion, deliriousness, unconsciousness, panic attacks, chest pain, difficulty breathing, vomiting, or seizures as these symptoms usually indicate drug intoxication or overdose.
Randox Toxicology’s Evidence MultiSTAT is a fully automated immunoanalyser that enables on-site simultaneous detection of up to 21 analytes from a single sample, making it ideal for an emergency department. It requires a small sample volume and generates results in 20 minutes. The process from sample entry to results can be completed in 3 simple steps, with minimum room for human error. The MultiSTAT is designed to analyse as quick, simple and reliable as possible.
| Available Tests | ||
| AB-CHMINACA | AB-PINACA | Amphetamine |
| Barbiturates | Benzodiazepines I (Oxazepam) | Benzodiazepines II (Lorazepam) |
| Benzoylecgonine (Cocaine Metabolite) | Buprenorphine | Cannabinoids (THC) |
| Creatinine | Ethyl Glucuronide (EtG) | Fentanyl |
| LSD | Methadone | Methamphetamine |
| Opiate | Oxycodone | Phencyclidine (PCP) |
| Pregabalin | Propoxyphene | Tramadol |
| Tricyclic Antidepressants (TCA) | UR-144/XLR-11 | α-PVP (Flakka) |
If you would like to find out more about the Evidence MultiSTAT, Biochip Array Technology, or our Evidence range of analysers, contact info@randoxtoxicology.com or visit www.randoxtoxicology.com
Randox Toxicology Products and Services
BIOCHIP
EVIDENCE
ELISA
MATRICES
Want to know more about Randox?
Contact us or visit our homepage to view more.
We Are Randox | Ladies GAA team reach final of Inter-Firms Tournament
Randox Ladies reach final of FinTrU Ulster GAA Football Inter-Firms Tournament
Early on the morning of Saturday 12th October 2019, Randox Ladies GAA team took to the field at the Mid Ulster Sports Arena, to compete in the FinTrU Ulster GAA Football Inter-Firms competition.
With teams made up of eight players, the format of the competition saw the ladies play five group games with the chance to qualify for the cup and shield finals.
Could they match or even beat their record from last year, having reached the 2018 semi-finals?
In the commentary below, John James Fallon, Randox Electrical Engineer and Bainisteoir / Coach for Randox Ladies GAA Team provides a match report from the big day.
John James commented;
Five consecutive games was a big ask for a squad that was relatively small when compared to other firms competing on the day. Nevertheless, our Randox GAA Ladies rose to the challenge and won their first match comfortably against Mallaghans.
The next game saw Randox face last year’s winners FinTrU, whose squad had some very experienced GAA players, and in the following match we competed against The GAA Store Team. Randox, who had grown in confidence after their first game, gave absolutely everything on the field but just came up short in two super games of football. This effort was not without cost as the ladies picked up a few injuries along the way but battled on regardless.
The ladies then showed great character and hunger to bounce back and defeat Options IT, a victory which saw them reach the shield final against our previous opponents Mallaghans.
From the first whistle the ladies put everything on the line, running themselves into the ground despite injury and fatigue. The first half was anyone’s for the taking but it was the fresher Mallaghans who took advantage of their bigger squad to take the early lead and went into half time with a 5-point advantage.
Our Randox Ladies were not about to lie down and accept defeat however, and an early goal and a point swung the balance of the game back in our favour.
During such a tight and dynamic game however, the leading team continued to change, and against the run of play Mallaghans went down the field to score a goal.
In these circumstances a lesser team may have conceded the game, however our ladies immediately responded with a goal and with only seconds remaining looked like they could emerge victorious.
Unfortunately though, despite a courageous effort, we could not find the breakthrough. Congratulations to Mallaghans who went on to win a very entertaining game of football, and subsequently the tournament shield. Thank you to FinTrU and Ulster GAA for organising another fantastic day out.
What a fantastic achievement for this small group of dedicated and enthusiastic players in reaching the final, some of whom had never played Gaelic football before and only had three training sessions before fielding on Saturday. The ladies should be extremely proud of themselves and with the men’s competition only two weeks away, the bar once again has been set extremely high. Well done Randox Ladies!
There are still spaces available on the Randox GAA Men’s team who play their competition on the 26th October at Queen’s University Malone Playing Fields Dub Pavilion.
If you are interested in joining a Randox GAA team or helping out, please send your name and contact details to John James Fallon in our engineering team: johnjames.fallon@randox.com
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our Randox Products and Services
REAGENTS
RX SERIES
ACUSERA
BIOCHIP
We Are Randox | Randox IT is shortlisted in the Belfast Telegraph IT Awards 2019
Congratulations to the Randox IT department who have been shortlisted in two categories at the Belfast Telegraph IT Awards 2019.
This, the inaugural event from the Belfast-based media outlet, is set to be a showcase of the finest that the Northern Ireland IT industry has to offer with both IT agencies and in-house IT teams vying for the chance to be crowned among the best their respective fields.
Randox IT have been shortlisted for IT Project Team of the Year for their work on RIQAS Point of Care and IT Team of the Year for their work on the Randox Health client and staff portal.
See an overview of their applications below;
IT Project Team of the Year
Randox IT have developed an innovative health portal that assesses the accuracy and reliability of blood testing analysers. These blood testing analysers are increasingly being placed in the likes of pharmacies, GP surgeries, and A&E departments to provide NHS Health Checks and manage long term conditions.
Randox IT cloud-based technology provides confidence in vital test results for conditions like diabetes and heart disease. Uptake of the scheme has increased considerably since it was launched this year, proving that the system is meeting a need for a quality assurance system for non-laboratory health service staff which was not being met before.
IT Team of the Year
The in-house IT team at world-leading health diagnostics firm Randox comprises of web developers, engineers, customer support staff, web designers, security professionals, software development and software testers spanning ten nationalities, from Indian to Hungarian and Italian to South African.
In the last year, the Randox IT team have created a fully-automated, fully-functional platform for both healthcare professionals and clients of Randox Health, which generates results for state-of-the-art health checks.
The finals for the Belfast Telegraph IT Awards 2019 will take place on Friday 8th November 2019 in The Mac, Belfast and all finalists can be viewed here.
Good luck to the Randox IT department!
Want to know more?
Contact us or visit our Randox Careers